SAN FRANCISCO -- Operators had a favorable early experience using the Tendyne transcatheter mitral valve replacement (TMVR) system for severe mitral regurgitation (MR) and mitral annular calcification ...
WASHINGTON (January 10, 2023) – In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study ...
PHOENIX, AZ—Symptomatic patients with moderate-to-severe mitral regurgitation (MR) ineligible for surgery fare quite well with transapical (TA) transcatheter mitral valve replacement (TMVR), with more ...
UPMC Heart and Vascular Institute in Central Pa. today announced that its doctors treated a patient using the Half Moon Medical transcatheter mitral repair technology (Half Moon TMVr System). This ...
MUNSTER — Cardiovascular specialists of Community Healthcare System successfully have performed the first transcatheter mitral valve replacement procedure in Northwest Indiana, the hospital system ...
TRINITY is a global prospective, multicenter, single-arm clinical trial, which primarily aims to evaluate the safety and efficacy of LuX-Valve Plus in application on patients with severe tricuspid ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach to receive U.S. Food and ...
Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making it the first minimally invasive, catheter-based treatment that uses a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback